Fasiglifam，TAK-875
Product Detail
Product Tags
| Pack Size | Availability | Price (USD) |
Chemical Name:
(S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid
SMILES Code:
O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3)=CC=C12
InChi Code:
InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1
InChi Key:
BZCALJIHZVNMGJ-HSZRJFAPSA-N
Keyword:
1000413-72-8；CAS:1000413-72-8；CAS：1000413-72-8；TAK875；TAK-875；TAK 875；Fasiglifam
Solubility: Soluble in DMSO, not in water
Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
Description:
Fasiglifam (TAK-875) is an effective, oral, and selective GPR40 agonist.
Target: GPR40 agonist
